<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

3 min read

Back on Track: Q320 Total Joints Market Recap

12/4/20 11:39 AM

Q320 Total JointsTrain with LogoAfter the pandemic derailed the market in Q220, Total Joints was getting back on track in Q3

The COVID-19 pandemic derailed the Total Joints Market in Q220 with stay-at-home orders and elective procedure shutdowns. But the market seemed back on track in Q320 as elective procedural volumes increased and revenues neared pre-COVID levels. With the market chugging along, the US Total Joints Market experienced positive growth during the quarter of +2.5%, according to SmartTRAK Financial Dashboard. The Hip Market was able to quickly gain steam due to the less elective nature of the procedure compared to Knees. In Q320, the US Hip Market grew +7.6% compared to the US Knee Market which was nearing pre-COVID levels at -1.1%.

Among the many topics covered in the comprehensive Q320 Total Joints Market Recap* are:

  • Complete Total Joints Market Overview
  • Companies' Revenue and Market Shares
  • Knee Overview including Q320 Highlights
  • Hip Overview including Q320 Highlights
  • Q320 Regulatory Highlights

For Q320, Zimmer Biomet remained at the top of the US Knee Replacement Market with XXX Blurred PERCENTAGE V2% share followed by Stryker, JNJ/DePuy Synthes and Smith & Nephew and Other companies. Zimmer Biomet retained the top spot in the US Hip Replacement Market with XXX Blurred PERCENTAGE V2-1% share with Stryker in second place, slightly above JNJ/DePuy Synthes and then followed by Smith & Nephew and ...

Read the entire Q320 Total Joints Market Recap including news, data, charts, company revenues, shares and analysis*

*The entire article and the links can only be viewed by SmartTRAK subscribers to this module. For more information on how to receive a demo and subscribe, please click the button below.

Learn More
Lisa Mahan
Written by Lisa Mahan

20+ years' experience in orthopedic industry, including 12 years at J&J DePuy Orthopaedics. Competitive Intelligence Analyst and e-Marketing manager at J&J DePuy Orthopaedics.

  • There are no suggestions because the search field is empty.

Follow Us on Social Media

Recent Articles

SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services.

Contact Us

info@smarttrak.com

3943 Irvine Blvd. #150
Irvine, CA 92602

Sign up for the blog Newsletter

© BioMedGPS, LLC. All rights reserved.